Figure S4 from Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis
<p>Figure S4 shows the Evaluation of the utility of regarding the 95% CI RR for late-stage incidence as a “forecast” of the final trial result for cancer-specific mortality, only including 15 trial arm comparisons with the late-stage outcome RR reported prior to the primary analysis for mortality but after the screening period had ended.</p>
Authors
- Robert Allen Smith (ORCID: https://orcid.org/0000-0003-3344-2238)
- Julia Geppert (ORCID: https://orcid.org/0000-0001-6446-6094)
- Peter David Sasieni (ORCID: https://orcid.org/0000-0003-1509-8744)
- Chris Stinton (ORCID: https://orcid.org/0009-0003-2419-7688)
- Matejka Rebolj (ORCID: https://orcid.org/0000-0001-9597-645X)
- Stephen William Duffy (ORCID: https://orcid.org/0000-0003-4901-7922)
- Bethany Shinkins (ORCID: https://orcid.org/0000-0001-5350-1018)
- Ruth Etzioni (ORCID: https://orcid.org/0000-0002-9164-6370)
- Sam M. Janes (ORCID: https://orcid.org/0000-0002-6634-5939)
- Samantha Johnson (ORCID: https://orcid.org/0000-0002-4716-1229)
- Matthew J. Randell (ORCID: https://orcid.org/0000-0001-5856-3007)
- Sian Taylor‐Phillips (ORCID: https://orcid.org/0000-0002-1841-4346)
- Adam R. Brentnall (ORCID: https://orcid.org/0000-0001-6327-4357)
- Karoline Freeman (ORCID: https://orcid.org/0000-0002-9963-2918)
- Nefeli Kouppa (ORCID: https://orcid.org/0009-0004-8827-3085)
Publication Details
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1158/1055-9965.30271520
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00